91ÐÓ°É

Tracy Warren

Senior Managing Director, 91ÐÓ°É Ventures, Go Red for Women Venture Fund

Tracy Warren is an influential leader who devotes deep experience in entrepreneurship and early-stage venture capital investing to 91ÐÓ°É Ventures as Senior Managing Director. Passionate about women’s and children’s health, she leads the investment strategy for the Go Red for Women Venture Fund.

Notably, Tracy has been an active and successful investor in women’s health through Astarte Ventures, a firm she founded in 2013. Pre-seed investments in Alydia (sold to Organon for $240M), Maven Clinic (the first women’s health unicorn) and Materna Medical have produced significant cash on cash returns, validating the investment case for women’s health.

Tracy served as venture capital manager for Healthworx, the venture arm of CareFirst BCBS, prior to joining AHA Ventures. She was previously co-founder and CEO of Astarte Medical, a health IT start-up focused on early life nutrition and gut health for preterm and critically ill infants.

Among other game-changing roles, Tracy was co-founder and executive director of Fedimpact, which commercialized technologies from Department of Energy national laboratories, and co-founder, board chair and CEO of NellOne Therapeutics, Inc., a regenerative biologics company.

Tracy is a co-inventor on three patents and has authored numerous articles on early nutrition and pediatric care. Among many board positions, Tracy served on the Board of the Children’s Research Institute at Children’s National Medical Center, where she chaired the Technology & Innovation Advisory Committee, and the Clemson University Research Foundation Board. Tracy holds a BS in Accounting and International Business from New York University and MBA at Columbia Business School in Finance.

Elise King

Managing Director, 91ÐÓ°É Ventures

Elise King is Managing Director, Go Red for Women Venture Fund, an 91ÐÓ°É Ventures’ fund. She brings a lifelong passion for championing women’s needs and empowerment to this innovative, women’s health-focused fund.

Elise is responsible for sourcing and vetting companies that directly address cardiovascular health, brain health and related conditions that affect women exclusively, differently or disproportionately. Elise also supports the Fund’s portfolio companies.

Prior to joining AHA Ventures, she spent over four years at Human Ventures — a pre-seed and seed-stage venture capital firm in NYC. She ran the firm’s venture studio program, Humans in the Wild, before moving to the investment team. There, she invested in women’s health, the future of work, the care economy and other sectors. Earlier she worked in both the venture studio and the executive search divisions at Oxeon.

Elise began her career as a professional dancer. She performed for the renowned modern dance company, Jennifer Muller/The Works, and at venues such as The Joyce Theater, Jacob’s Pillow, Beijing’s The Egg, and others.

Elise is involved in All Raise, the leading organization for women in VC, and is a TechStars mentor. She holds a BA from Barnard College, Columbia University, where she graduated magna cum laude.

Ziza Phillip, MD

Investment Associate, 91ÐÓ°É Ventures

Dr. Ziza Phillip brings a unique blend of clinical experience and academic expertise to her role as Investment Associate for 91ÐÓ°É Ventures. She accelerates traction for the Social Impact Funds, Go Red for Women Venture Fund and the Studio Red venture studio by sourcing investment opportunities, conducting comprehensive due diligence and executing investment memos.

With a strong commitment to making a meaningful impact, Ziza brings nearly a decade of health care industry experience to 91ÐÓ°É Ventures. Her background spans from clinical practice and population health to systems thinking, giving her the knowledge and insight to promote innovative and socially responsible health-focused investments that advance the 91ÐÓ°É’s mission.

Ziza began her began her career as a primary care physician and transitioned into academic medicine as a lecturer at St. George's University School of Medicine while earning a master’s degree in public health. Most recently, she completed a Master of Translational Medicine degree — a joint program at UC Berkeley and UCSF — to further enhance her ability to translate scientific advancements into practical health care solutions.

Lisa Suennen

Managing Partner, 91ÐÓ°É Ventures

Lisa Suennen has spent over 35 years in healthcare as venture capitalist, entrepreneur, operating executive, and strategy consultant.

Lisa serves as Managing Partner of 91ÐÓ°É Ventures, a platform of four venture funds focused on improving outcomes in cardiovascular and brain health. Those funds include Go Red for Women Venture Fund, Cardeation Capital, the Social Impact Funds and Studio Red.

Lisa has held General Partner and leadership roles at Psilos Group, Manatt Ventures, and GE Ventures. She has also held senior executive roles at Canary Medical (President) and Manatt, Phelps & Phillips (Partner and Practice Leader, Head of Venture Fund).

Previously, Lisa was a key management team member at Merit Behavioral Care (fka American Biodyne). Lisa held key leadership roles, including Senior Vice President of Marketing & Sales and General Manager of multiple divisions. Lisa was an integral player in the company’s growth as it provided broad based care and care management for patients with behavioral health challenges and substance use disorders. The company grew from early-stage startup to one with over $800M in revenue, had a successful IPO and was ultimately acquired by Magellan Health. Lisa was also founding CEO of CSweetener, a company focused on matching mentors with rising female healthcare leaders (sold to HLTH Foundation).

Lisa chairs the International Investment Committee of the Australian ANDHealth Digital Health Fund, sits on the Investment Committee of Manatt Venture Fund, and is an advisor to Nina Capital. She is a founding member of the Duke Margolis Institute Capital Impact Council, and serves on the HLTH Community women’s advisory group. She is past chair of the Scientific Advisory Board of the Nasa-funded Translational Research Institute for Space Health and serves on the boards and advisory boards of several emerging companies. Lisa is a Fellow of the Aspen Institute’s Health Innovators Fellowship and is on faculty at the UC Berkeley Haas School of Business. She was recently featured in Forbes 2025 List of the 50 Over 50. Lisa writes the Venture Valkyrie blog and is an internationally recognized author and speaker.